Skip to main content

Advertisement

Log in

Late adverse reactions to intravascular iodine based contrast media: an update

  • Contrast Media
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Definition

Late adverse reactions (LAR) to contrast media (CM) are defined as reactions occurring 1 h to 1 week after exposure.

Need for review

In view of more prospective studies of LAR and new data about their pathophysiology, the Contrast Medium Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) reviewed the literature on LAR and updated their guidelines.

Clinical features and pathology

LAR after CM include symptoms such as nausea, vomiting, headache, itching, skin rash, musculoskeletal pain, and fever. Skin reactions are well-documented LAR to CM with an incidence of approximately 2%–4% after nonionic monomers. LAR are commoner by a factor of three to four after nonionic dimers. The commonest skin reactions are maculopapular rashes, erythema and skin swelling. These reactions are T cell-mediated immune reactions, and the diagnosis may be confirmed using skin tests (patch or delayed reading intradermal). The main risk factors for LAR are a previous reaction to contrast medium, a history of allergy, and interleukin-2 treatment. Most skin reactions are mild or moderate and self-limiting.

Management

Management is symptomatic and similar to the management of other drug-induced skin reactions. To reduce the risk of repeat reactions avoidance of the relevant CM and any cross-reacting agents identified by skin testing is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Panto PN, Davies P (1986) Delayed reactions to urographic contrast media. Br J Radiol 59:41–44

    Article  PubMed  CAS  Google Scholar 

  2. Webb JAW, Stacul F, Thomsen HS, Morcos SK, Members of the contrast media safety committee of the European Society of Urogenital Radiology (ESUR) (2003) Late adverse reactions to intravascular iodinated contrast media. Eur Radiol 13:181–184

    Article  PubMed  Google Scholar 

  3. Stacul F (2009) Late adverse reactions. In: Thomsen HS, Webb JA (eds) Contrast media. Safety issues and ESUR guidelines, 2nd revised edition. Springer, Berlin, pp 123–127

    Google Scholar 

  4. Namasivayam S, Kalra MK, Torres WE, Small WC (2006) Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 12:210–215

    Article  PubMed  Google Scholar 

  5. Idée JM, Pinès E, Prigent P, Corot C (2005) Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19:263–281

    Article  PubMed  Google Scholar 

  6. Khachman D, Gandia P, Sallerin F, Mailly F (2009) Mise au point sur les réactions d’hypersensibilité immédiate et tardive aux produits de contraste iodés. Thérapie 64:331–339

    Article  PubMed  Google Scholar 

  7. Guéant-Rodriguez RM, Romano A, Barbaud A et al (2006) Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 12:3359–3372

    Article  PubMed  Google Scholar 

  8. Bohm I, Schild HH (2006) A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions. Eur Radiol 16:1570–1579

    Article  PubMed  Google Scholar 

  9. Beyer-Enke SA, Zeitler E (1993) Late adverse reactions to non-ionic contrast media: a cohort analytic study. Eur Radiol 3:237–241

    Article  Google Scholar 

  10. Yasuda R, Munechika H (1998) Delayed adverse reactions to non-ionic monomeric contrast-enhanced media. Invest Radiol 33:1–5

    Article  PubMed  CAS  Google Scholar 

  11. Ueda S, Mori H, Matsumoto S et al (2001) True delayed adverse reactions to non-ionic contrast media: does it really exist? Eur Radiol Suppl 11:377

    Google Scholar 

  12. Schild H (1996) Delayed allergy-like reactions in patients: monomeric and dimeric contrast media compared with plain CT. Eur Radiol 6:9–10

    Article  Google Scholar 

  13. Schild HH, Kuhl CK, Hubner-Steiner U et al (2006) Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology 240:56–64

    Article  PubMed  Google Scholar 

  14. Loh S, Bagheri S, Katzberg RW, Fung MA et al (2010) Delayed adverse reaction to contrast-enhanced CT: a prospective single-center study comparison to control group without enhancement. Radiology 255:764–771

    Article  PubMed  Google Scholar 

  15. Higashi TS, Katayama M (1990) The delayed adverse reactions of low osmolar contrast media. Nippon Igaku Hoshasen Gakkai Zasshi 50:1359–1366

    PubMed  CAS  Google Scholar 

  16. Choyke PL, Miller DL, Lotze MT et al (1992) Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 183:111–114

    PubMed  CAS  Google Scholar 

  17. Yoshikawa H (1992) Late adverse reactions to nonionic contrast media. Radiology 183:737–740

    PubMed  CAS  Google Scholar 

  18. Cochran ST, Cugley AL, Kiourmehr F (1993) Delayed reactions in patients receiving non-ionic contrast media. Adv X-ray Contrast 1:61–62

    Google Scholar 

  19. Mikkonen R, Kontkanen T, Kivisaari L (1995) Acute and late adverse reactions to low-osmolal contrast media. Acta Radiol 36:72–76

    PubMed  CAS  Google Scholar 

  20. Pedersen SH, Svaland MG, Reiss A-L, Andrew E (1998) Late allergy-like reactions following vascular administration of radiography contrast media. Acta Radiol 39:344–348

    PubMed  CAS  Google Scholar 

  21. Rydberg J, Charles J, Aspelin P (1998) Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium. Acta Radiol 39:219–222

    PubMed  CAS  Google Scholar 

  22. Bartolucci F, Cecarini M, Gabrielli G et al (2000) Reazioni tardive a un mezzo di contrasto radiologico (iopamidolo). Radiol Med 100:273–278

    PubMed  CAS  Google Scholar 

  23. Hosoya T, Yamaguchi K, Akutzu T et al (2000) Delayed adverse reactions to iodinated contrast media and their risk factors. Radiat Med 18:39–45

    PubMed  CAS  Google Scholar 

  24. Munechika H, Hiramatsu Y, Kudo S, Sugimura K et al (2003) A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 13:185–194

    Article  PubMed  Google Scholar 

  25. Munechika H, Hiramatsu M, Nakamura H et al (1999) Large-scale study of delayed adverse events to non-ionic contrast medium, iohexol: incidence and risk factors of adverse events following non-interventional radiography. Eur Radiol 9:440

    Google Scholar 

  26. Sutton AGC, Finn P, Campbell PG et al (2003) Early and late reactions following the use of Iopamidol 340, Iomeprol 350 and Iodixanol 320 in cardiac catheterization. J Invasive Cardiol 5:133–138

    Google Scholar 

  27. Yamaguchi K, Takanashi I, Kanauchi T et al (1992) A retrospective survey of delayed adverse reactions to ionic and nonionic contrast media. Nippon Igaku Hoshasen Gakkai Zasshi 52:1565–1570

    PubMed  CAS  Google Scholar 

  28. McCullough M, Davies P, Richardson R (1989) A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br J Radiol 62:260–265

    Article  PubMed  CAS  Google Scholar 

  29. Bertrand P, Delhommais A, Alison D, Rouleau P (1995) Immediate and delayed tolerance of iohexol and ioxaglate in lower limb phlebography: a double-blind comparative study in humans. Acad Radiol 2:683–686

    Article  PubMed  CAS  Google Scholar 

  30. Oi H, Yamazaki H, Matsushita M (1997) Delayed vs immediate adverse reactions to ionic and non-ionic low-osmolality contrast media. Radiat Med 15:23–27

    PubMed  CAS  Google Scholar 

  31. Sutton AGC, Finn P, Grech ED et al (2001) Early and late reactions after the use of iopamidol 340, ioxaglate 320 and iodixanol 320 in cardiac catheterization. Am Heart J 141:677–683

    Article  PubMed  CAS  Google Scholar 

  32. Lapi F, Cecchi E, Pedone C, Attanasio F et al (2008) Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals. Eur J Clin Pharmacol 64:723–737

    Article  PubMed  CAS  Google Scholar 

  33. Fransson SG, Stenport G, Andersson M (1996) Immediate and late adverse reactions in coronary angiography. A comparison between iodixanol and ioxaglate. Acta Radiol 37:218–222

    PubMed  CAS  Google Scholar 

  34. Niendorf HP (1996) Delayed allergy-like reactions to X-ray contrast media. Problem statement exemplified with iotrolan (Isovist) 280. Eur Radiol 6:S8–S10

    Google Scholar 

  35. Bigby M, Jick S, Jick H, Arndt K (1986) Drug induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975–1982. J Am Med Assoc 256:3358–3363

    Article  CAS  Google Scholar 

  36. Christiansen C, Pichler WJ, Skotland T (2000) Delayed allergy-like reactions to X-ray contrast media: mechanistic considerations. Eur Radiol 10:1965–1975

    Article  PubMed  CAS  Google Scholar 

  37. Kanny G, Pichler W, Morisset M et al (2005) T-cell mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activations tests. J Allergy Clin Immunol 115:179–185

    Article  PubMed  CAS  Google Scholar 

  38. Romano A, Viola M, Gaeta F, Rumi G et al (2008) Patch testing in non-immediate drug eruptions. Allergy Asthma Clin Immunol 4:66–74

    Article  PubMed  CAS  Google Scholar 

  39. Brockow K, Romano A, Aberer W, Bricher AJ et al (2009) Skin testing in patients hypersensitivity reactions to iodinated contrast media—a European multicenter study. Allergy 64:234–241

    Article  PubMed  CAS  Google Scholar 

  40. Brockow K, Christiansen C, Kanny G et al (2005) Management of hypersensitivity reactions to iodinated contrast media. Allergy 60:150–158

    Article  PubMed  CAS  Google Scholar 

  41. Christiansen C (2002) Late-onset allergy-like reactions to X-ray contrast media. Curr Opin Allergy Clin Immunol 2:333–339

    Article  PubMed  Google Scholar 

  42. Watanabe H, Sueki H, Nakada T et al (1999) Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium. Dermatology 198:291–294

    Article  PubMed  CAS  Google Scholar 

  43. Brockow E, Becker EW, Worret W-I, Ring J (1999) Late skin test reactions to radiocontrast medium. J Allergy Clin Immunol 104:1107–1108

    Article  PubMed  CAS  Google Scholar 

  44. Akiyama M, Nakada T, Sueki H et al (1998) Drug eruption caused by nonionic iodinated X-ray contrast media. Acad Radiol 5:S159–S161

    Article  PubMed  Google Scholar 

  45. Courvoisier S, Bircher AJ (1998) Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium. Allergy 53:1221–1224

    Article  PubMed  CAS  Google Scholar 

  46. Gall H, Pillekamp H, Peter R-U (1999) Late-type allergy to the X-ray contrast medium Solutrast (iopamidol). Contact Dermatitis 40:248–250

    Article  PubMed  CAS  Google Scholar 

  47. Vernassiere C, Trechot P, Commun N et al (2004) Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatis 50:359–366

    Article  CAS  Google Scholar 

  48. Antunez C, Barbaud A, Gomez E et al (2011) Recognition of iodixanol by dendritic cells increases the cellular response in delayed allergic reactions to contrast media. Clin Exp Allergy 41:657–664

    Article  PubMed  CAS  Google Scholar 

  49. Goodfellow T, Holdstock GE, Brunton FJ, Bamforth J (1986) Fatal acute vasculitis after high-dose urography with iohexol. Br J Radiol 59:620–621

    Article  PubMed  CAS  Google Scholar 

  50. Reynolds NJ, Wallington TB, Burton JL (1993) Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol 129:82–85

    Article  PubMed  CAS  Google Scholar 

  51. Savill JS, Barrie R, Ghosh S et al (1988) Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus. Postgrad Med J 64:392–394

    Article  PubMed  CAS  Google Scholar 

  52. Sadi AM, Toda T, Kiyuna M et al (1995) An autopsy case of malignant lymphoma with Lyell’s syndrome. J Dermatol 22:594–599

    PubMed  CAS  Google Scholar 

  53. Conroy RM, Bjartveit K, Sheppick A et al (1994) Iodixanol in intravenous urography: a comparison of iodixanol 270 mg I/ml, iodixanol 320 mg I/ml and iopamidol 300 mg I/ml (NIOPAM). Clin Radiol 49:337–340

    Article  PubMed  CAS  Google Scholar 

  54. Fischbach R, Landwehr P, Lackner K et al (1996) Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase III trial. Eur Radiol 6:9–13

    Article  PubMed  CAS  Google Scholar 

  55. Rosado A, Canto G, Veleiro B, Rodriguez J (2001) Toxic epidermal necrolysis after repeated injections of iohexol. Am J Roentgenol 176:262–263

    CAS  Google Scholar 

  56. Schick E, Weber L, Gall H (1996) Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid. Contact Dermatitis 35:312

    Article  PubMed  CAS  Google Scholar 

  57. Sedano E, Vega JM, Rebollo S et al (2001) Delayed exanthema to nonionic contrast medium. Allergy 56:1015–1016

    Article  PubMed  CAS  Google Scholar 

  58. Kanny G, Marie B, Hoen B et al (2001) Delayed adverse reaction to sodium ioxaglic acid-meglumine. Eur J Dermatol 11:134–137

    PubMed  CAS  Google Scholar 

  59. Aoki Y, Takemura T (2002) Allergies correlated to adverse reactions induced by nonionic monomeric and ionic dimeric contrast media for contrast enhanced CT examinations. Radiol Technol 58:1245–1251

    CAS  Google Scholar 

  60. Mikkonen R, Vehmas T, Granlund H, Kivisaari L (2000) Seasonal variation in the occurrence of late adverse skin reactions to iodine-based contrast media. Acta Radiol 41:390–393

    Article  PubMed  CAS  Google Scholar 

  61. Vavricka SR, Halter J, Furrer K et al (2002) Contrast media triggering cutaneous graft-versus-host disease. Bone Marrow Transplant 29:899–901

    Article  PubMed  CAS  Google Scholar 

  62. Fishman JE, Aberle DR, Moldawer NP et al (1991) Atypical contrast reactions associated with systemic interleukin-2 therapy. Am J Roentgenol 156:833–834

    CAS  Google Scholar 

  63. Oldham RK, Brogley J, Braud E (1990) Contrast medium “recalls” interleukin-2 toxicity. J Clin Oncol 8:942–943

    PubMed  CAS  Google Scholar 

  64. Shulman KL, Thompson JA, Benyunes MC et al (1993) Adverse reactions to intravenous contrast media in patients treated with interleukin-2. J Immunother Emphasis Tumor Immunol 113:208–212

    Google Scholar 

  65. Zukiwski AA, David CL, Coan J et al (1990) Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration. Cancer 65:1521–1524

    Article  PubMed  CAS  Google Scholar 

  66. Schnyder B, Frutig K, Mauri-Hellweg D et al (1998) T-cell mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction. Clin Exp Allergy 28:1412–1417

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Henrik S. Thomsen.

Additional information

Members of the Committee: H.S. Thomsen (Chairman, Denmark), S.K. Morcos (Secretary, United Kingdom), T. Almén (Sweden), P. Aspelin (Sweden), M.F. Bellin (France), O. Clement (France), G. Heinz-Peer (Austria), P. Reimer (Germany), F. Stacul (Italy), A.J. van der Molen (the Netherlands), J.A.W. Webb (United Kingdom). Consultants to the committee: J-M Idée (Guerbet, France), P. Lengsfeld (Bayer Schering Pharma, Germany), A. Spinazzi (Bracco, Italy), ESUR: www.esur.org

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bellin, MF., Stacul, F., Webb, J.A.W. et al. Late adverse reactions to intravascular iodine based contrast media: an update. Eur Radiol 21, 2305–2310 (2011). https://doi.org/10.1007/s00330-011-2200-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-011-2200-9

Keywords

Navigation